Oesophageal carcinoma

  title={Oesophageal carcinoma},
  author={Arjun Pennathur and Michael K Gibson and Blair A Jobe and James D. Luketich},
  journal={The Lancet},

Figures and Tables from this paper

Gastro-Oesophageal Cancer
The epidemiology, aetiology and clinical aspects of gastro-oesophageal cancer are explored, as well as the treatment practices in different parts of the world and their impact on survival.
A multinational review: Oesophageal cancer in low to middle-income countries
Factors that contribute to the development of this disease in different geographical areas and genetic mechanisms governing these findings are discussed and the preventative treatment options for the disease are discussed.
Review: Surveillance of patients with Barrett oesophagus.
FDG PET in oesophagogastric cancer
The role of PETCT in oesophagogastric malignancy has become of increasing importance over the last decade, and the main role currently is in the staging of the tumour to plan the most appropriate therapy for each patient, alongside other techniques.
Adenosquamous Carcinoma of the Esophagus: A Literature Review
An audit of the available literature was performed and a review on the epidemiology, pathogenesis, histopathology, clinical manifestations, diagnosis, treatment and prognosis of ASCs were synthesized.
Endoscopic management of Barrett's and early oesophageal neoplasia
Dysplasia and intramucosal cancer arising in BO can safely be treated with endoscopic eradication therapy (EET) due to the low risk of subsequent lymph node metastasis and the mainstay of treatment is endoscopic resection of visible lesions for accurate staging.
Histopathological landscape of rare oesophageal neoplasms
The aim of this review is to provide a comprehensive characterization of the main morphological and clinical features of these rare variants of oesophageal neoplastic lesions.
Esophageal carcinoma.
The 5-year survival rate for patients with esophageal cancer, although generally poor, has improved during the past decade, and long-term survival is increasingly possible for Patients with early or locally advanced disease.


Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past
Chemoprevention of oesophageal cancer and the AspECT trial.
  • D. Das, A. Chilton, J. Jankowski
  • Medicine
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2009
The AspECT trial is the biggest, multicentre, randomised controlled clinical trial looking at the long-term chemoprevention effect of esomeprazole with or without aspirin, and more than 85% of the participants tolerated the medications at the initial intended doses, and the drop-out rate has been 7%.
Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.
Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus and the patients of this cohort would not have benefited from an endoscopic surveillance programme.
Surgical aspects of the patient with high-grade dysplasia.
The natural history of high grade dysplasia (HGD), difficulties in the diagnosis, the incidence of adenocarcinoma in resected specimens and the surgical aspects in the treatment of HGD, including minimally invasive esophagectomy are discussed.
Esophageal cancer: epidemiology, pathogenesis and prevention
Intensive research into risk factors combined with the ability to identify precursor lesions has paved the way for studies of chemoprevention for esophageal cancer, some of which have shown promising results.
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.
Rapid increases in the incidence of adenocarcinoma rates rose among white men and women in all stage and age groups, indicating that these increases are real and not an artifact of surveillance.
The epidemiology of esophageal cancer.
Examination of epidemiological aspects of cancers of the esophagus suggests that nutritional deficiencies and, possibly, ingestion of mycotoxins and nitrosamines are factors for the development of esophageal cancer.
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
There is a strong and probably causal relation between gastroesophageal reflux and esophageaal adenocarcinoma, and the relation between reflux And gastric cardia is relatively weak.